RUB » Bibliotheksportal

Zahra Moinfar, Hannes Dambach, Bodo A. Schoenebeck, Eckart Förster, Nora Prochnow, Pedro Faustmann

• \(\bf Introduction\) Glioma is the most common malignant primary brain tumour with male preponderance and poor prognosis. Glioma cells express variable amounts of connexin 43 (Cx43) and estrogen receptors (ERs). Both, Cx43 and ERs, play important roles in cell proliferation and migration. Therefore, we investigated the effects of 17-\(\beta\) estradiol (E2) on Cx43 expression in twoglioma cell lines with variable native expression of Cx43. \(\textbf {Materials and Methods}\) F98 and C6 rat glioma cells were cultured for 24 h in the presence of 10 nM or 100 nM E2, and the E2-antagonist, Fulvestrant. An MTT assay was performed to evaluate cell viability. ER\(\alpha\),ER\(\beta\) and Cx43 protein expressions were analysed by western blotting and Cx43 mRNA expression was analysed by real-time polymerase chain reaction. To quantify cell migration, an exclusive zone migration assay was used. Functional coupling of cells via gap junctions was examined using whole-cell patch-clamp technique. \(\bf Results\) E2 reduced Cx43 expression in C6 cells, but increased Cx43 expression in F98 cultures. These effects were mediated via ERs. Moreover, E2 promoted C6 cell migration, but it did not affect F98 cell migration. The expression level of ER\(\alpha\) was found to be high in C6, but low in F98 cells. ER\(\beta\) was exclusively expressed in C6 cells. In addition, E2 treatment induced a significant decrease of ER\(\beta\) in C6 cultures, while it decreased ER\(\alpha\) expression in F98 glioma cells. \(\bf Discussion\) These findings show that E2 differentially modulates Cx43 expression in F98 and C6 glioma cells, likely due to the differential expression of ERs in each of these cell lines. Our findings point to the molecular mechanisms that might contribute to the gender-specific differences in the malignancy of glioma and could have implications for therapeutic strategies against glioma.